Assessment of some Physiological Biomarkers in COVID-19 Patients in Thi-Qar, Iraq

J Jouda1, E Abdul Kareem Jabbar2, F Salih Abdulhadi1

  • 1Department of Biology, College of Sciences, Mustansiriyah University, Baghdad, Iraq.

Insights

Biomarkers like lactate dehydrogenase (LDH), D-Dimer, vitamin D, and ferritin are associated with COVID-19 prognosis. Age, BMI, employment, and residency also impact disease distribution and severity.

Area of Science:

  • Biochemistry and Molecular Biology
  • Epidemiology
  • Clinical Medicine

Background:

  • COVID-19 prognosis is influenced by various biomarkers and demographic factors.
  • Understanding these associations is crucial for patient management and public health strategies.

Purpose of the Study:

  • To evaluate the association of lactate dehydrogenase (LDH), D-Dimer, vitamin D, and ferritin levels with COVID-19 prognosis.
  • To investigate the prevalence of COVID-19 risk factors including age, employment status, BMI, and residency in Iraqi patients.

Main Methods:

  • A case-control study involving 200 COVID-19 patients and 100 controls in Thi-Qar, Iraq.
  • Collection of demographic data (age, gender, residency, employment) and measurement of BMI.
  • Analysis of blood samples for LDH, D-Dimer, vitamin D, ferritin, oxygen saturation, and pulse rate.

Main Results:

  • COVID-19 patients exhibited significantly lower vitamin D levels and higher concentrations of LDH, serum ferritin, and D-Dimer compared to controls.
  • Obesity and overweight were prevalent among patients (47% and 40%, respectively).
  • Age over 40, rural residency, and employment status were noted in a significant proportion of patients.

Conclusions:

  • LDH, D-Dimer, vitamin D, and ferritin are potential biomarkers for assessing COVID-19 severity.
  • Demographic factors such as age, BMI, employment status, and place of residency may contribute to COVID-19 risk and distribution.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
137
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
227